Concepedia

Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial

Farid H. Mahmud, Petter Bjornstad, Cheril Clarson, Antoine Clarke, Samantha J. Anthony, Yesmino Elia, Lynne McArthur, Luc Mertens, Rahim Moineddin, Susan Kirsch,

Nature Medicine · 2025 · 15 citations · 41 references

DOIFull text

Open access

Concepts

References

41

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text

, , +15

KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero et al. · Kidney International · 2024 · 7.4K citations · Full text

, , +17

Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation

Thomas H. Hostetter, Jean L. Olson, Helmut G. Rennke et al. · American Journal of Physiology-Renal Physiology · 1981 · 1.7K citations

, , +17

Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus

David Z.I. Cherney, Bruce A. Perkins, Nima Soleymanlou et al. · Circulation · 2013 · 1.3K citations · Full text

, , +17

Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial

Ofri Mosenzon, Stephen D. Wiviott, Avivit Cahn et al. · The Lancet Diabetes & Endocrinology · 2019 · 675 citations · Full text

, , +14